Navigation Links
PDHI Launches Short Form of Its ConXus Profile Health Assessment
Date:3/16/2009

BERNARDSVILLE, N.J., March 16 /PRNewswire/ -- Protocol Driven Healthcare, Inc. (PDHI) now offers a short form of its health risk assessment (HRA), the ConXus(R) Profile. The shorter format facilitates completion by populations with low literacy and reduces processing costs of paper assessments. The short form does not replace the original, longer adult HRA, but joins PDHI's suite of ConXus applications, which includes assessments for students, children, and Spanish-speaking adults.

Employers can deliver both long and short forms to the same population or subgroup and can switch between long and short forms from year to year. Aggregate reports support both versions when deployed within the same population and time period.

"While the short-form HRA does not comply with NCQA HIP 1 or evalu8 standards, it does provide a robust option for employers to collect health data from hard-to-reach employees," said Jennifer Jolley, president of PDHI. "The abbreviated format also satisfies a request from many of our clients to deliver a solution that saves paper-processing costs while maintaining reporting integrity."

The short-form HRA includes about 40 instead of 70 questions. The user report shrinks to about 5 pages, and the paper questionnaire to 4 pages. The short form delivers all the functionality required to assess a participant's current health risk, omitting chronic and future disease risks on the long form.

The short-form HRA uses the same file structure as the long version, which simplifies ongoing version control. Both long and short versions of the HRA are available in English and Spanish and can be taken online or on paper.

Recent News

PDHI -- PDHI Adds Diabetes and Heart Disease Prevention to ConXus Steps Library of Action Plans http://www.pdhi.com/webnew/corporate/pressreleases/Diabetes.asp

PDHI - PDHI's Health Risk Appraisal and Consumer Health Tools Awarded NCQA HIP Certification

http://www.pdhi.com/webnew/corporate/pressreleases/NCQA.asp

About Protocol Driven Healthcare, Inc

PDHI is a healthcare technology and data processing organization that provides preventive health applications and services using the ConXus(R) health improvement platform. ConXus solutions are scalable and flexible, driving process efficiency and project control for clients. PDHI has adopted an open-systems approach, including extensive administrative tools and interfaces that allow integration of ConXus solutions into client portal environments. For more information, visit http://www.pdhi.com/.

    Contact:
    David Abel
    Vice President of Sales and Marketing
    908-315-0365, ext. 1026
    davida@pdhi.com

    Paul N. Greenwood
    Executive Vice President of Business Development
    515-277-1376, ext. 1224
    paulg@pdhi.com


'/>"/>
SOURCE Protocol Driven Healthcare, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. Novozymes Launches Enzyme to Reduce Acrylamide in Food
3. Enova Medical Launches Exos Corporation
4. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
5. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
6. ThirdBiotech Networking Group Launches
7. BioReliance Launches Next-Generation Genotoxicity Screening Service
8. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
9. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
10. Kingfisher Healthcare Launches Breakthrough Product in Europe
11. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced ... to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B ... to cross the cell membrane and bind intracellular STAT3 and inhibit its function. ...
(Date:10/10/2017)... PA (PRWEB) , ... October 10, 2017 , ... ... City Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives ... the award for Excellence in Volunteer Experience from US2020. , US2020’s mission is ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
Breaking Biology Technology:
(Date:3/30/2017)... March 30, 2017  On April 6-7, 2017, Sequencing.com ... Genome hackathon at Microsoft,s headquarters in ... will focus on developing health and wellness apps that ... Hack the Genome is the first hackathon for ... world,s largest companies in the genomics, tech and health ...
(Date:3/28/2017)... PUNE, India , March 28, 2017 ... (Analog, IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), ... Maintenance), Vertical, and Region - Global Forecast to 2022", ... 30.37 Billion in 2016 and is projected to reach ... 15.4% between 2017 and 2022. The base year considered ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by ... Global Forecast to 2022", published by MarketsandMarkets, the market is expected to be ... 2017 and 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):